Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2026-07-31 18:00:17 ET · period of report 2026-07-29 · accession 0001861477-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-31 18:00 | 2026-07-29 | ACAD | Thompson Elizabeth H.Z. | EVP, Head of Research, Dev | M - OptEx | — | +32.3K | 35.6K | +984% | — |
| DM | 2026-07-31 18:00 | 2026-07-30 | ACAD | Thompson Elizabeth H.Z. | EVP, Head of Research, Dev | S - Sale+OE | $26.13 | -16.6K | 19.0K | -47% | -$432.7K |
| D | 2026-07-31 18:00 | 2026-07-29 | ACAD | Thompson Elizabeth H.Z. | EVP, Head of Research, Dev | M - OptEx | $0.00 | -32.3K | 32.3K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-29 | M | A | 32,272 | — | 35,552 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2026-07-30 | S | D | 16,508 | $26.13 | 19,044 | D | — | — | (F2) The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). |
| 3 | Common | Common Stock | 2026-07-30 | S | D | 50 | $26.17 | 18,994 | D | — | — | (F2) The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). |
| 4 | Derivative | Restricted Stock Units | 2026-07-29 | M | D | 32,272 | $0.00 | 32,272 | D | — · — to — | 32,272 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) 50% of the restricted stock units vested on July 29, 2026 and 25% vest on each of July 29, 2027 and July 29, 2028. (F3) 50% of the restricted stock units vested on July 29, 2026 and 25% vest on each of July 29, 2027 and July 29, 2028. |